Iron deficiency, but not underfeeding reduces the secretion of interferon-gamma by mitogen-activated murine spleen cells

被引:18
作者
Kuvibidila, Solo R. [1 ,2 ]
Gardner, Renee [3 ,4 ]
Velez, M. [3 ,4 ]
Yu, L. [3 ,4 ]
机构
[1] Oklahoma State Univ, Dept Nutr Sci, Stillwater, OK 74078 USA
[2] Tulane Univ, Med Ctr, Dept Pediat, Div Res, New Orleans, LA 70118 USA
[3] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA 70118 USA
[4] Childrens Hosp, Res Inst, New Orleans, LA 70118 USA
关键词
Iron deficiency; Interferon-gamma; Mice; Spleen; IL-12; IFN-GAMMA; MEDIATED-IMMUNITY; SALMONELLA-TYPHIMURIUM; CYTOKINE PRODUCTION; HUMAN MACROPHAGES; T-CELLS; MICE; EXPRESSION; INTERLEUKIN-10; INFECTION;
D O I
10.1016/j.cyto.2010.08.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interferon-gamma (IFN-gamma), a cytokine primarily secreted by T and natural killer cells regulates cell-mediated and innate immunity. Iron deficiency, a public health problem in children impairs immune function. To determine whether reduced IFN-gamma contributes to impaired immunity, we measured IFN-gamma in supernatants of activated (2.5 mu g/ml concanavalin A, 50 ng/ml anti-CD3 antibody) spleen cells from control (C), iron-deficient (ID), pair-fed (PF), and iron-replete mice for 3 (R3) and 14 days (R14) (11-12/group). Except for iron content, the low iron (5 ppm) and control (50 ppm) diets had identical composition. Mean indices of iron status after 51 days of feeding were as follows: C = PF approximate to R14 > R3 > ID (p < 0.01). Iron deficiency, but not pairfeeding reduced IFN-gamma concentration in mitogen-treated cells by 30-43% (p < 0.05); iron repletion improved it. Reduced IFN-gamma was not simply due to differences in IL-12 (IFN-gamma inducer), percentage of CD3+ T cells, or impaired cell proliferation because these indices were not always decreased. It was likely due to a defect in T cell activation that leads to IFN-gamma gene expression. IFN-gamma positively correlated with indicators of iron status, body, and thymus weights (r = 0.238-0.472; p < 0.05). Reduced IFN-gamma secretion during iron deficiency may affect response to infections. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:230 / 237
页数:8
相关论文
共 38 条
[1]  
ABBAS AK, 1977, CELLULAR MOL IMMUNOL, P278
[2]  
Ahn HJ, 1997, J IMMUNOL, V159, P2125
[3]   TRANSFERRIN, IRON, AND SERUM-LIPIDS ENHANCE OR INHIBIT MYCOBACTERIUM-AVIUM REPLICATION IN HUMAN MACROPHAGES [J].
DOUVAS, GS ;
MAY, MH ;
CROWLE, AJ .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (04) :857-864
[4]  
FARRAR MF, 1986, J IMMUNOL, V137, P3836
[5]   Induction of antimicrobial pathways during early-phase immune response to Salmonella spp. in murine macrophages:: Gamma interferon (IFN-γ) and upregulation of IFN-γ receptor alpha expression are required for NADPH phagocytic oxidase gp91-stimulated oxidative burst and control of virulent Salmonella spp. [J].
Foster, N ;
Hulme, SD ;
Barrow, PA .
INFECTION AND IMMUNITY, 2003, 71 (08) :4733-4741
[6]  
GASTGHEYB D, 2007, ETHNIC DIS, V17, P41
[7]   Gamma interferon enhances internalization and early nonoxidative killing of Salmonella enterica serovar typhimurium by human macrophages and modifies cytokine responses [J].
Gordon, MA ;
Jack, DL ;
Dockrell, DH ;
Lee, ME ;
Read, RC .
INFECTION AND IMMUNITY, 2005, 73 (06) :3445-3452
[8]   Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis [J].
Grunig, G ;
Corry, DB ;
Leach, MW ;
Seymour, BWP ;
Kurup, VP ;
Rennick, DM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (06) :1089-1099
[9]   Systemic infection of mice by wild-type but not Spv(-) Salmonella typhimurium is enhanced by neutralization of gamma interferon and tumor necrosis factor alpha [J].
Gulig, PA ;
Doyle, TJ ;
ClareSalzler, MJ ;
Maiese, RL ;
Matsui, H .
INFECTION AND IMMUNITY, 1997, 65 (12) :5191-5197
[10]   The effects of iron deficiency on lymphocyte cytokine production and activation: preservation of hepatic iron but not at all cost [J].
Jason, J ;
Archibald, LK ;
Nwanyanwu, OC ;
Bell, M ;
Jensen, RJ ;
Gunter, E ;
Buchanan, I ;
Larned, J ;
Kazembe, PN ;
Dobbie, H ;
Jarvis, WR .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 126 (03) :466-473